Genomic analysis of the emergence and evolution of multidrug resistance during a klebsiella pneumoniae outbreak including carbapenem and colistin resistance

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 3, 2014, Pages 632-636

  López Camacho, Elena ^a   Gómez Gil, Rosa ^a   Tobes, Raquel ^b   Manrique, Marina ^b   Lorenzo, María ^a   Galván, Beatriz ^c   Salvarelli, Estefanía ^a   Moatassim, Youssef ^a   Salanueva, Iñigo J ^d   Pareja, Eduardo ^b   Codoñer, Francisco M ^e   Alvarez Tejado, Miguel ^d   Garcillán Barcia, María Pilar ^f   De la Cruz, Fernando ^f   Mingorance, Jesús ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b Oh no sequences Research group Era7 Bioinformatics   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Roche Diagnostics Spain ^*  (Spain)

^e Lifesequencing SL   (Spain)

^f CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; CARBAPENEM DERIVATIVE; COLISTIN;

ADULT; AGED; BACTERIAL GENOME; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; EPIDEMIC; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MUTATION RATE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE; EVOLUTION, MOLECULAR; FEMALE; GENOME, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION RATE; SEQUENCE ANALYSIS, DNA;

EID: 84894034432     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt419     Document Type: Article

References (18)

1. Jacoby GA. AmpC b-lactamases. Clin Microbiol Rev 2009; 22: 161-82.
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI,Wayne, PA, USA, 2007.
3. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee. EUCAST technical note on tigecycline. Clin Microbiol Infect 2006; 12: 1147-9.
4. Hamzehpour MM, Pechere J, Plesiat P. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Microbiology 1995; 39: 2392-6.
5. Diancourt L, Passet V. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-82.
6. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
7. Cendejas E, Gómez-Gil R, Gómez-Sánchez P et al. Detection and characterization of Enterobacteriaceae producing metallo-b-lactamases in a tertiary-care hospital in Spain. Clin Microbiol Infect 2010; 16: 181-3.
8. Tobes R, Codoñer FM, López-Camacho E et al. Genome sequence of Klebsiella pneumoniae KpQ3, a DHA-1 b-lactamase-producing nosocomial isolate. Genome Announc 2013; 1: e00167-12.
9. Tribuddharat C, Fennewald M. Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 960-2.
10. Illiaquer M, Caroff N, Bémer P et al. Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period. Diagn Microbiol Infect Dis 2012; 74: 95-7.
11. Diestra K, Miró E, Martí C et al. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin Microbiol Infect 2011; 17: 1032-6.
12. Karageorgopoulos DE, Wang R, Yu X-H et al. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother 2012; 67: 255-68.
13. Paño-Pardo JR, Ruiz-Carrascoso G, Navarro-San Francisco C et al. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak. J Antimicrob Chemother 2013; 68: 89-96.
14. Lippa AM, Goulian M. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet 2009; 5: e1000788.
15. Miller AK, Brannon MK, Stevens L et al. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother 2011; 55: 5761-9.
16. Lee J-Y, Lim MH, Heo ST et al. Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1patient. Diagn Microbiol Infect Dis 2012; 72: 267-71.
17. Aathithan S, French GL. Hypermutability in clinical isolates of Klebsiella pneumoniae isuncommonand is unrelated to ciprofloxacin resistance. Int J Antimicrob Agents 2010; 36: 239-42.
18. Cannatelli A, D'Andrea MM, Giani T et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 2013; 57: 5521-6.